Skip to content
Search

Latest Stories

Fluoxetine 40mg capsules back in pharmacy shelves to meet normal demand  

Following the expiry of SSP06 on October 2, there is now sufficient stock of Fluoxetine 40mg capsules to meet the normal demand.

Community pharmacies have been advised to dispense the drug prescribed after October 2. Fluoxetine 40mg capsules should be supplied to the patients in accordance with the prescription, as the SSP will no longer be valid for use.


Contractors should ensure that their SSP claims are appropriately submitted to NHS Business Services Authority for reimbursement.

Pharmacy teams are advised to submit SSP claims using the EPS token if their PMR systems do not support or capture all the SSP endorsement requirements for a valid claim.

If using a token to submit SSP claims, to avoid double-claiming, contractors are reminded to mark the item covered by the SSP as ‘Not Dispensed’/’ND’ on the EPS message.

Contractors have also been advised to check that the correct number of patient charges are collected and declared on the end of month FP34C submission form.

SSPs will be accepted for up to three calendar months after expiry or withdrawal of the SSP.

NHS BSA advises that contractor SSP claims should be clear and unambiguous and follow the protocol guidelines – NHS BSA processing staff must be able to determine what has been supplied.

Pharmacy contractors should keep a record of all SSP claims and reconcile when their Schedule of Payments are sent.

More For You

Impact of National Insurance rise on community pharmacies.

Pharmacies are faced with higher NI payments

Pic credit: Istock

Pharmacies to pay higher national insurance contributions after MPs refuse to back amendments to bill


Community pharmacies are faced with paying the higher rate of national insurance contributions that come into force next month after MPs on Wednesday (19) rejected amendments to a bill that was approved by the House of Lords.

Keep ReadingShow less
Novo Nordisk regains ABPI membership after two-year suspension

Novo Nordisk was suspended in March 2023 for sponsoring pharmacy weight management training courses.

Image Credit: Novo Nordisk

Novo Nordisk’s ABPI suspension lifted after two years

Novo Nordisk has regained full membership of the Association of the British Pharmaceutical Industry (ABPI) after a two-year suspension due to serious breaches of the ABPI Code of Practice.

The reinstatement follows rigorous audits of the company’s compliance procedures and governance by the Prescription Medicines Code of Practice Authority (PMCPA).

Keep ReadingShow less
NICE calls for annual BMI checks for adults with long-term conditions

Annual BMI measurements create early intervention opportunities for weight management

Getty Images

NICE seeks feedback on annual BMI checks for adults with long-term conditions

The National Institute for Health and Care Excellence (NICE) has published a draft quality standard recommending annual Body mass index (BMI) and waist-to-height measurements for adults with long-term conditions to help prevent weight-related complications.

A consultation has been launched to gather feedback from healthcare professionals and commissioners on the feasibility of implementing these proposals within the NHS.

Keep ReadingShow less
Medicine shortages: Penny-pinching costs taxpayers more, warns CCA

Pharmacies are forced to dispense medicines at a loss or face stock shortages.

Getty Images

Government’s penny-pinching approach driving medicine shortages, CCA warns

The Company Chemists’ Association (CCA) has warned the government's longstanding drive to save pennies on the medicines bill is leading to avoidable medicine shortages, ultimately costing taxpayers more.

In a newly released paper, the CCA highlighted how the government has squeezed the price it is willing to pay for many medicines, making the UK a less attractive market for pharmaceutical manufacturers and suppliers.

Keep ReadingShow less
Morrison: Pharmacy contract news

Janet Morrison

Morrison: Pharmacy contract news “before the start of the financial year”


Community pharmacies will get clarity over a new funding contract before the start of the financial year, according to Community Pharmacy England (CPE) chief executive Janet Morrison.

Keep ReadingShow less